Animal models of FVIIa gene expression: their role in the future development of haemophilia treatment

Tekijä OBERGFELL, A., NICHOLS, T., EZBAN, M.
Julkaistu 2010

Human platelets express Endothelial Protein C Receptor which can be utilized to enhance localization of Factor VIIa activity

Tekijä Fager, A. M., Machlus, K. R., Ezban, M., Hoffman, M.
Julkaisussa J Thromb Haemost (2018)

Locations of disulfide bonds and free cysteines in the heavy and light chains of recombinant human factor VIII (antihemophilic factor A).

Tekijä McMullen, B. A., Fujikawa, K., Davie, E. W., Hedner, U., Ezban, M.
Julkaistu 1995

Pharmacokinetics, pharmacodynamics and safety of recombinant canine FVIIa in a study dosing one haemophilia A and one haemostatically normal dog

Tekijä KNUDSEN, T., KRISTENSEN, A. T., NICHOLS, T. C., AGERSØ, H., JENSEN, A. L., KJALKE, M., EZBAN, M., TRANHOLM, M.
Julkaistu 2011

Pharmacokinetics and ex vivo whole blood clot formation of a new recombinant FVIII (N8) in haemophilia A dogs

Tekijä KARPF, D. M., KJALKE, M., THIM, L., AGERSØ, H., MERRICKS, E. P., DEFRIESS, N., NICHOLS, T. C., EZBAN, M.
Julkaistu 2011

Pharmacokinetics and pharmacodynamics of turoctocog alfa and N8-GP in haemophilia A dogs

Tekijä AGERSØ, H., STENNICKE, H. R., PELZER, H., OLSEN, E. N., MERRICKS, E. P., DEFRIESS, N. A., NICHOLS, T. C., EZBAN, M.
Julkaistu 2012